07/15/2026 | Press release | Distributed by Public on 07/16/2026 07:48
Laboratory Corporation of America (Labcorp), a national clinical diagnostics company, has agreed to pay $14,500,000 to resolve allegations that it violated the False Claims Act by submitting false claims to Medicare Part B (Medicare) for medically unnecessary urine drug testing (UDT) for some patients conducted pursuant to a testing panel offered by Labcorp, called "Toxassure Comprehensive."